- Home
- PAC vs MEDP Comparison
PAC vs MEDP Comparison
Compare PAC & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- MEDP
- Stock Information
- Founded
- PAC 1998
- MEDP 1992
- Country
- PAC Mexico
- MEDP United States
- Employees
- PAC N/A
- MEDP N/A
- Industry
- PAC Aerospace
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PAC Consumer Discretionary
- MEDP Health Care
- Exchange
- PAC Nasdaq
- MEDP Nasdaq
- Market Cap
- PAC 11.7B
- MEDP 13.4B
- IPO Year
- PAC 2006
- MEDP 2016
- Fundamental
- Price
- PAC $215.80
- MEDP $585.82
- Analyst Decision
- PAC Hold
- MEDP Hold
- Analyst Count
- PAC 5
- MEDP 11
- Target Price
- PAC $210.00
- MEDP $451.70
- AVG Volume (30 Days)
- PAC 85.9K
- MEDP 350.9K
- Earning Date
- PAC 10-20-2025
- MEDP 10-22-2025
- Dividend Yield
- PAC 5.23%
- MEDP N/A
- EPS Growth
- PAC 13.32
- MEDP 25.36
- EPS
- PAC 1.07
- MEDP 14.32
- Revenue
- PAC $1,870,491,921.00
- MEDP $2,358,373,000.00
- Revenue This Year
- PAC $58.23
- MEDP $21.48
- Revenue Next Year
- PAC $7.61
- MEDP $11.90
- P/E Ratio
- PAC $20.11
- MEDP $41.14
- Revenue Growth
- PAC 35.46
- MEDP 13.88
- 52 Week Low
- PAC $168.62
- MEDP $250.05
- 52 Week High
- PAC $259.33
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- PAC 42.84
- MEDP 62.02
- Support Level
- PAC $206.91
- MEDP $572.12
- Resistance Level
- PAC $222.95
- MEDP $602.54
- Average True Range (ATR)
- PAC 5.67
- MEDP 20.93
- MACD
- PAC 1.09
- MEDP -0.69
- Stochastic Oscillator
- PAC 57.91
- MEDP 59.40
About PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.